Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Olympus Corp ADR (OCPNY)

Olympus Corp ADR (OCPNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 23,146,056
  • Shares Outstanding, K 1,285,892
  • Annual Sales, $ 7,733 M
  • Annual Income, $ 1,030 M
  • 60-Month Beta 0.70
  • Price/Sales 3.03
  • Price/Cash Flow 14.76
  • Price/Book 5.24
Trade OCPNY with:
  • Price/Earnings ttm 22.26
  • Earnings Per Share ttm 0.51
  • Most Recent Earnings $0.15 on 08/09/22
  • Next Earnings Date 02/03/23
  • Annual Dividend & Yield 0.08 (0.44%)
  • Most Recent Dividend 0.078 on 03/29/22
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.17
  • Growth Rate Est. (year over year) +587,547.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.3000 +4.05%
on 01/06/23
19.2199 -6.35%
on 01/18/23
+0.1200 (+0.67%)
since 12/30/22
3-Month
17.2000 +4.65%
on 12/28/22
23.0000 -21.74%
on 11/15/22
-3.1200 (-14.77%)
since 10/31/22
52-Week
16.8000 +7.14%
on 03/16/22
74.9900 -76.00%
on 09/09/22
-3.3000 (-15.49%)
since 01/28/22

Most Recent Stories

More News
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

NPPXF : 0.9000 (unch)
NTTYY : 23.0300 (+0.30%)
OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
OLYMY : 15.7300 (-1.99%)
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
OLYMY : 15.7300 (-1.99%)
Olympus Names Dr. John de Csepel as Chief Medical Officer

Olympus Names Dr. John de Csepel as Chief Medical Officer

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
OLYMY : 15.7300 (-1.99%)
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases

Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
OLYMY : 15.7300 (-1.99%)
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision

Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
OLYMY : 15.7300 (-1.99%)
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
OLYMY : 15.7300 (-1.99%)
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd

Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years

Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam

Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)
Olympus Announces Launch of Olympus Asia Pacific Innovation Program

Olympus Announces Launch of Olympus Asia Pacific Innovation Program

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.8100 (-4.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others...

See More

Key Turning Points

3rd Resistance Point 18.0000
2nd Resistance Point 18.0000
1st Resistance Point 18.0000
Last Price 18.0000
1st Support Level 18.0000
2nd Support Level 18.0000
3rd Support Level 18.0000

See More

52-Week High 74.9900
Fibonacci 61.8% 52.7614
Fibonacci 50% 45.8950
Fibonacci 38.2% 39.0286
Last Price 18.0000
52-Week Low 16.8000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar